Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2010
08/25/2010CN101810593A Elemene sustained-release tablets
08/25/2010CN101810592A Pharmaceutical preparation comprising an active dispersed on a matrix
08/25/2010CN101810591A Mangiferin dispersible tablets and preparation method thereof
08/25/2010CN101810590A Buccal tablets taking salbutamol sulfate and ambroxol hydrochloride as main active ingredients and preparation method thereof
08/25/2010CN101810589A Pills taking salbutamol sulfate and ambroxol hydrochloride as main active ingredients and preparation method thereof
08/25/2010CN101810588A Pantoprazole sodium freeze-drying medicinal composition for injection and preparation method thereof
08/25/2010CN101810587A Preparation technology for microspheric embolization agent
08/25/2010CN101810586A L-dopa methyl ester sustained-release microsphere composite and preparation method thereof
08/25/2010CN101810585A Invertose (fructose/glucose) medicinal composition microsphere injection
08/25/2010CN101810584A Microsphere injection of medicinal composition of cefotiam hydrochloride and anhydrous sodium carbonate
08/25/2010CN101810583A HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere
08/25/2010CN101810582A Method for preparing veterinary tilmicosin microspheres
08/25/2010CN101810581A Technological measure for enhancing content uniformity of clenbuterol hydrochloride and application thereof
08/25/2010CN101810580A Valsartan liposome, preparation method thereof and medicinal composition containing same
08/25/2010CN101810579A Oral spray or aerosol containing Palonosetron
08/25/2010CN101810577A Gossypol intravenous injection fatty emulsion for curing tumors
08/25/2010CN101810576A Puerarin self-microemulsion composition based on mixed oil and preparation method thereof
08/25/2010CN101810575A Bifendate composition and preparation method thereof
08/25/2010CN101810574A Method for preparing stable docetaxel submicron emulsion injection and freeze-dried emulsion
08/25/2010CN101810573A Diammonium glycyrrhizinate microemulsion and preparation process thereof
08/25/2010CN101810571A Ibuprofen slow-release suspension and preparation method thereof
08/25/2010CN101810570A Lipid nano particle preparation containing composite formed fatty acid and anthracyclines antitumor antibiotics and preparation method thereof
08/25/2010CN101810569A Enrofloxacin injection liquid and preparation method thereof
08/25/2010CN101810568A Injection containing ibuprofen and preparation method thereof
08/25/2010CN101810567A Small molecular group water eye drops
08/25/2010CN101810566A Hydrocortisone butyrate cream
08/25/2010CN101810565A Tolterodine gel preparation and preparation method thereof
08/25/2010CN101810564A Method for preparing water-soluble nanometer preparation by insoluble traditional Chinese medicine containing ring structures
08/25/2010CN101810563A Tacrolimus ophthalmic in-situ gel preparation and preparation method thereof
08/25/2010CN101810562A Nasal in situ gel containing cortical hormone
08/25/2010CN101810561A Hirudin polyion micelle composition
08/25/2010CN101810560A Cyclosporine A polymeric micelles composition
08/25/2010CN101810559A Hirudin polyion micelle composition of targeted platelet
08/25/2010CN101810547A Fast dissolving orally consumable films
08/25/2010CN101810186A Multifunctional disinfectant and preparation method thereof
08/25/2010CN101513428B Preparation for preventing livestock locoweed poisoning
08/25/2010CN101433525B Method for preparing colon positioning compression-coated tablets
08/25/2010CN101361713B Curcumin nano crystallization preparation and preparation method thereof
08/25/2010CN101336895B Novel alkalized solid-liquid two-state skin quick-anaesthesia nano-emulsion and preparation method thereof
08/25/2010CN101239041B High molecule liposome and uses thereof
08/25/2010CN101190891B Dihydrazide compound and its preparation method and application
08/25/2010CN101186706B Preparation method for PEG series gel nano particles
08/25/2010CN101181474B Chinese medicine ointment for curing skin diseases as well as producing and detecting method thereof
08/25/2010CN101164537B High-efficient oral silibinin sustained-release preparation and preparation method thereof
08/25/2010CN101138560B Nitrofuran gelling agent and method of preparing the same
08/25/2010CN101121676B Water gelling agent used for forming supermolecule hydrogel and preparation method thereof
08/25/2010CN101108252B Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same
08/25/2010CN101099729B Oral solid preparation containing ambroxol hydrochloride and salbutamol active components
08/25/2010CN101085310B Traditional Chinese medicine ointment for treating cow mastitis and method for preparing same
08/25/2010CN101041076B Controlled ointment compound stroma and the preparing method
08/25/2010CN101011467B Preparation method of fructus schisandrae sphenantherae dropping pills
08/25/2010CN101002947B Target medicine used for treating bacteriosis, and its preparing method
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781489 Microemulsions of retinoids, and pharmaceutical compositions containing them
08/24/2010US7781429 solubilizing a nonsteroidal antiinflammatory drug (NSAID) such as diclofenac by combining with at least two of camphor, menthol and thymol
08/24/2010US7781417 Cyclodextrin dimers and derivatives thereof, methods for preparing them and their use, in particular, for the solubilizing pharmacologically active substances
08/24/2010US7781406 Modulating a transplantation-associated immune response for acute and chronic graft versus host disease (GVHD); kidney, heart and liver allogeneic transplantation; side effect reduction; biodrugs
08/24/2010US7781208 Methods and means for targeted gene delivery
08/24/2010US7781161 Detection cancer; controlling gene expression; detection hybrids
08/24/2010US7781009 Sugar-free hard coatings prepared from liquid maltitol comprising DP4+fraction
08/24/2010US7780996 reducing serum total cholesterol levels by administering effective doses of an extract of Emblica officinalis prepared by pulping fruits of Emblica officinalis with demineralized water to create a slurry, treating the slurry with pectinase, filtering, concentrating
08/24/2010US7780988 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
08/24/2010US7780987 Coating comprising aqueous dispersion of neutral ester copolymer without functional groups, polyglycol having melting point greater than 55 degrees C, pharmaceutically acceptable excipients, coated onto pharmaceutical oral dosage form, cured; FDA Orange book listed patent for metformin HCl
08/24/2010US7780986 Method of preparing sustained-release preparations of quinolone antibiotics
08/24/2010US7780983 Amphoteric liposomes
08/24/2010US7780982 Biodegradable hyaluronic acid derivative and biodegradable polymeric micelle composition
08/24/2010US7780980 pharmaceutically acceptable hydrogel polymers of natural or synthetic origin or hybrids are introduced in a dry, less hydrated state and rehydrated to undergo a volumetric expansion and to affect sealing, plugging of tissue; implants
08/24/2010US7780978 Oral pharmaceutical compositions and methods of using the same
08/24/2010US7780977 Medication compositions
08/24/2010US7780968 Clostridial toxin derivatives and methods for treating pain
08/24/2010US7780967 Reduced toxicity Clostridial toxin pharmaceutical compositions
08/24/2010US7780958 A biocompatible crosslinking polymer comprising acrylamide and methylene bis-acrylamide; medical procedure involves injection of polyacrylamide gel under the mucous membrane
08/24/2010US7780957 Polyethylene glycol/polycation block copolymers
08/24/2010US7780951 Vaccines for immunization against Helicobacter
08/24/2010CA2617140C Pharmaceutical formulation with high stability and dissolution and manufacturing process
08/24/2010CA2548457C Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same
08/24/2010CA2536206C Pharmaceutical products comprising bisphosphonates
08/24/2010CA2464906C Improved endoprosthetic device
08/24/2010CA2463072C Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith
08/24/2010CA2462510C Wipe formulation
08/24/2010CA2427520C Hydrophilic polymer blends used for dry cow therapy
08/24/2010CA2426883C Methylphenidate modified release formulations
08/24/2010CA2386932C Dispersion with nonionic emulsifier
08/24/2010CA2386278C Dip coating compositions containing starch or dextrin
08/24/2010CA2377560C Incorporation and applications of biomolecular interactions within a carrier
08/24/2010CA2362757C Effervescent pharmaceutical formulation containing metamizole
08/24/2010CA2348493C Textured and porous silicone rubber
08/24/2010CA2213560C Pharmaceutical compositions for controlled release of soluble receptors
08/24/2010CA2201396C Multifunctional molecular complexes for gene transfer to cells
08/24/2010CA2172509C Methods and compositions for microencapsulation of antigens for use as vaccines
08/19/2010WO2010093873A2 Drug delivery through hydrogel plugs
08/19/2010WO2010093528A2 On-demand and reversible drug release by external cue
08/19/2010WO2010093523A2 Foamable microemulsion compositions for topical administration
08/19/2010WO2010093460A2 Particle size-structured parenteral dispersions
08/19/2010WO2010093452A2 Reducible polymers for non-viral gene delivery
08/19/2010WO2010093382A1 Foamable benzoyl peroxide compositions for topical administration
08/19/2010WO2010093374A1 Compositions and methods for treating post-operative pain using bupivacaine and an anti-inflammatory agent
08/19/2010WO2010093285A1 Composition comprising biodegradable carrier for controlled drug delivery
08/19/2010WO2010093036A1 Cationic poly(amino acids) and uses thereof
08/19/2010WO2010093020A1 Hard capsule
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 1712